Back

Doxorubicin-induced cardiomyopathy: gene variant TRPC6 as therapeutic target

26 May 2019 (15:30 - 15:45)
Organised by:
Congress Presentation Part of: Young Investigator Award - Basic Science and Translational Science Cardio-Oncology HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Katelyn Bruno

Mayo Clinic, Jacksonville (United States of America)

5 More presentations in this session

Presentation thumbnail
GRK2 regulates the endothelial responsiveness to bradykinin: role in human angioedema
Doctor J. Gambardella (Napoly, IT)
Abstract Slides Video
Presentation thumbnail
Empaglifozin has cardioprotective and anti-inflammatory effects in mice during doxorubicin treatment
Doctor V. Quagliariello (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Sterol metabolism is differentially regulated in human induced pluripotent stem cell-derived cardiomyocytes of peripartum cardiomyopathy patients
Mr M. Hoes (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Gut microbiota composition and interactions with diet: dysbiosis in heart failure is partly related to lower fiber intake
Ms C. Mayerhofer (Oslo, NO)
Abstract
Presentation thumbnail
Diastolic function modulation via protein kinase G-dependent Ca2(+)/calmodulin-dependent protein kinase-II phosphorylation and oxidation
Ms M. Herwig (Bochum, DE)
Abstract

Access the full session

Session thumbnail
Young Investigator Award - Basic Science and Translational Science

The Event

Event poster

Heart Failure 2019

26 May 2019 15:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources